Toth Financial Advisory Corp Trims Stock Holdings in ProShares Ultra Nasdaq Biotechnology $BIB

Toth Financial Advisory Corp reduced its position in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIBFree Report) by 82.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 997 shares of the exchange traded fund’s stock after selling 4,629 shares during the quarter. Toth Financial Advisory Corp’s holdings in ProShares Ultra Nasdaq Biotechnology were worth $46,000 as of its most recent SEC filing.

Separately, PNC Financial Services Group Inc. acquired a new position in ProShares Ultra Nasdaq Biotechnology in the 1st quarter valued at about $48,000.

ProShares Ultra Nasdaq Biotechnology Price Performance

NASDAQ BIB opened at $58.09 on Monday. The company has a market cap of $58.67 million, a P/E ratio of 20.68 and a beta of 1.63. The stock has a 50-day moving average of $54.12 and a two-hundred day moving average of $48.76. ProShares Ultra Nasdaq Biotechnology has a 1-year low of $33.78 and a 1-year high of $68.00.

ProShares Ultra Nasdaq Biotechnology Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, July 1st. Investors of record on Wednesday, June 25th were paid a dividend of $0.1706 per share. The ex-dividend date was Wednesday, June 25th. This is a positive change from ProShares Ultra Nasdaq Biotechnology’s previous quarterly dividend of $0.13. This represents a $0.68 annualized dividend and a yield of 1.2%.

ProShares Ultra Nasdaq Biotechnology Company Profile

(Free Report)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.

Read More

Want to see what other hedge funds are holding BIB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIBFree Report).

Institutional Ownership by Quarter for ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)

Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.